166 related articles for article (PubMed ID: 20370487)
1. Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease.
Danielyan L; Klein R; Hanson LR; Buadze M; Schwab M; Gleiter CH; Frey WH
Rejuvenation Res; 2010; 13(2-3):195-201. PubMed ID: 20370487
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
5. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
10. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
11. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
13. High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
Taheri S; Yu J; Zhu H; Kindy MS
J Alzheimers Dis; 2016 Oct; 54(3):1061-1072. PubMed ID: 27567835
[TBL] [Abstract][Full Text] [Related]
14. Allicin ameliorates cognitive impairment in APP/PS1 mice via Suppressing oxidative stress by Blocking JNK Signaling Pathways.
Zhang H; Wang P; Xue Y; Liu L; Li Z; Liu Y
Tissue Cell; 2018 Feb; 50():89-95. PubMed ID: 29429523
[TBL] [Abstract][Full Text] [Related]
15. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
16. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
19. Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Imboden H; Hamel E
J Alzheimers Dis; 2016; 51(4):1183-95. PubMed ID: 26923013
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II does not directly affect Aβ secretion or β-/γ-secretase activity via activation of angiotensin II type 1 receptor.
Wang BR; Shi JQ; Zhang YD; Zhu DL; Shi JP
Neurosci Lett; 2011 Aug; 500(2):103-7. PubMed ID: 21704122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
